We are thrilled to announce the successful completion of an oversubscribed Series C to further accelerate our company’s growth.


Press Release_Oversubscribed Financing Round for HEMEX_210110_2



HEMEX is committed to changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare. For more information, visit https://hemex.ch/

One thought on “Oversubscribed Financing Round for HEMEX

  1. Daniel Kobi says:

    Lieber Pascal
    Herzliche Gratulation zur erfolgreichen Finanzierungsrunde!
    Bin selbst auch gespannt wie’s weiterläuft.
    Ich wünsche dir alles Gute und beste Grüsse

Leave a Reply

Your email address will not be published. Required fields are marked *